All Pharma News
Themis Medicare launches Lenzetto for treatment of menopausal symptoms

Themis Medicare launches Lenzetto for treatment of menopausal symptoms
INDIANPHARMAPOST
04 Jan 2023
Share Share
Themis Medicare revenue down 15.26%; Profit down 7.76%

Themis Medicare revenue down 15.26%; Profit down 7.76%
INDIANPHARMAPOST
09 Nov 2022
Share Share
Themis Medi bets big on antiviral drug for Covid

Themis Medi bets big on antiviral drug for Covid
Viswanath Pilla ECONOMIC TIMES
12 Jul 2022
Share Share
Themis Medicare’s VIRALEX bags approval against COVID-19, viral infections

Themis Medicare’s VIRALEX bags approval against COVID-19, viral infections
ET HEALTH
08 Jul 2022
Share Share
Themis gets DCGI’s nod to launch Inosine Pranobex to treat Covid-19

Themis gets DCGI’s nod to launch Inosine Pranobex to treat Covid-19
ECONOMIC TIMES
12 Mar 2022
Share Share
Themis Medicare`s antiviral drug, Viralex receives DCGI approval for Covid-19

Themis Medicare`s antiviral drug, Viralex receives DCGI approval for Covid-19
PHARMABIZ
09 Mar 2022
Share Share
Themis eyes phase 3 study for chikungunya vaccine

Themis eyes phase 3 study for chikungunya vaccine
Eric Sagonowsky FIERCE BIOTECH
12 Nov 2018
Share Share
Themis eyes phase 3 study for chikungunya vaccine

Themis eyes phase 3 study for chikungunya vaccine
Eric Sagonowsky FIERCE BIOTECH
12 Nov 2018
Share Share
Physicians recommend diclofenac as gold standard raised by health ministry

Physicians recommend diclofenac as gold standard raised by health ministry
Shardul Nautiyal PHARMABIZ
10 Aug 2018
Share Share
CEPI -Themis Bioscience to Advance Vaccines Against Lassa Fever & MERS

CEPI -Themis Bioscience to Advance Vaccines Against Lassa Fever & MERS
BUSINESSWIRE
07 Mar 2018
Share Share